BioCentury
ARTICLE | Company News

Cerulean management update

November 3, 2014 8:00 AM UTC

Cerulean Pharma Inc. (NASDAQ:CERU), Cambridge, Mass. Business: Drug delivery, Cancer Resigned: Oliver Fetzer as president, CEO and a director Transitioned: CBO Chris Guiffre to COO ...